The article ‘Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand’ is now available online.

The article “Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand” was accepted for publication in the International Journal of Infectious Diseases (IJID) on March 22, 2024.
You can find the full article at this link: Molnupiravir versus favipiravir in at-risk outpatients with COVID-1900092-4/fulltext.